Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD

Background: Prospective pharmacological studies on breathomics profiles in COPD patients have not been previously reported. We assessed the effects of treatment and withdrawal of an extrafine inhaled corticosteroid (ICS)-long-acting β(2)-agonist (LABA) fixed dose combination (FDC) using a multidimen...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Pharmacol
Autori principali: Montuschi, Paolo, Santini, Giuseppe, Mores, Nadia, Vignoli, Alessia, Macagno, Francesco, Shoreh, Rugia, Tenori, Leonardo, Zini, Gina, Fuso, Leonello, Mondino, Chiara, Di Natale, Corrado, D'Amico, Arnaldo, Luchinat, Claudio, Barnes, Peter J., Higenbottam, Tim
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2018
Soggetti:
Pharmacology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5914154/
https://ncbi.nlm.nih.gov/pubmed/29719507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.00258
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi